Neil Aronin
27Patents
8h-index
19Co-inventors
72Inventor score
Filing activity: Nov 14, 1997 → Jan 12, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9809817B2 | Oligonucleotide compounds for targeting huntingtin mRNA | Chemistry; Metallurgy | 30 | Active |
| US7947658B2 | RNA interference for the treatment of gain-of-function disorders | Chemistry; Metallurgy | 26 | Expired |
| US8680063B2 | RNA interference for the treatment of gain-of-function disorders | Chemistry; Metallurgy | 26 | Active |
| US8987222B2 | Single nucleotide polymorphism (SNP) targeting therapies for the treatment of huntington'S disease | Chemistry; Metallurgy | 23 | Active |
| US10435688B2 | Oligonucleotide compounds for targeting huntingtin mRNA | Chemistry; Metallurgy | 15 | Active |
| US10774327B2 | Oligonucleotide compounds for targeting huntingtin mRNA | Chemistry; Metallurgy | 14 | Active |
| US11230713B2 | Oligonucleotide compounds for targeting huntingtin mRNA | Chemistry; Metallurgy | 13 | Active |
| US10633653B2 | Bioactive conjugates for oligonucleotide delivery | Chemistry; Metallurgy | 12 | Active |
| US11753638B2 | Conjugated oligonucleotides | Chemistry; Metallurgy | 5 | Active |
| US11827882B2 | Modified oligonucleotides targeting SNPs | Chemistry; Metallurgy | 5 | Active |
| US10513710B2 | Exosomal loading using hydrophobically modified oligonucleotides | Chemistry; Metallurgy | 3 | Active |
| US9434943B2 | RNA interference for the treatment of gain-of-function disorders | Chemistry; Metallurgy | 2 | Active |
| US10457940B2 | AAV treatment of Huntington's disease | Chemistry; Metallurgy | 2 | Active |
| US10344277B2 | RNA interference for the treatment of gain-of-function disorders | Chemistry; Metallurgy | 1 | Active |
| US10945955B2 | Artificial exosome composition and related methods | Chemistry; Metallurgy | 1 | Active |
| US11299734B2 | RNA interference for the treatment of gain-of-function disorders | Chemistry; Metallurgy | 1 | Active |
| US9914924B2 | Methods and compositions for treating neurological disease | Chemistry; Metallurgy | 1 | Active |
| US11046957B2 | AAV treatment of Huntington's disease | Chemistry; Metallurgy | 1 | Active |
| US12023407B2 | Artificial exosome composition and related methods | Chemistry; Metallurgy | 0 | Active |
| US11773392B2 | AAV treatment of Huntington's disease | Chemistry; Metallurgy | 0 | Active |
| US12077755B2 | Bioactive conjugates for oligonucleotide delivery | Chemistry; Metallurgy | 0 | Active |
| US12173286B2 | Fully stabilized asymmetric siRNA | Chemistry; Metallurgy | 0 | Active |
| US11767527B2 | Modified oligonucleotides targeting SNPs | General | 0 | Revoked |
| US12024706B2 | Modified oligonucleotides targeting SNPs | Chemistry; Metallurgy | 0 | Active |
| US11505807B2 | Exosomal loading using hydrophobically modified oligonucleotides | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.